How one company profited while delaying Narcan's drugstore debut
The push to make the lifesaving opioid overdose antidote easier to buy took five years and multiple court battles, fueling worries about access and supply.
Stay updated with breaking news from Robert Kramer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The push to make the lifesaving opioid overdose antidote easier to buy took five years and multiple court battles, fueling worries about access and supply.
#1-Ranked Industry Analyst Patrick Moorhead digs into the announcements about generative AI and other developments from the recent Google Cloud Next event.
VP & Principal Analyst, Datacenter Compute, Matt Kimball, shares interesting announcements and his takeaways from VMware Explore 2023.
Key Insights Insiders appear to have a vested interest in Appian's growth, as seen by their sizeable ownership The top...
VP & Principal Analyst, Enterprise Data Technologies, Robert Kramer explains a unique project that united art with enterprise data—and helped grow a business.